Ocugen

(NASDAQ) OCGN

Current Price$1.79

Market Cap$609.33M

Since IPO (2019)-37%

5 Year-86%

1 Year+144%

1 Month+1%

Ocugen Financials at a Glance

Market Cap

$609.33M

Revenue (TTM)

$4.41M

Net Income (TTM)

$67.85M

EPS (TTM)

$-0.23

P/E Ratio

-7.98

Dividend

$0.00

Beta (Volatility)

2.02 (High)

Dividend

$0.00

Beta (Volatility)

2.02 (High)

Price

$1.79

Volume

19,850

Open

$1.73

Price

$1.79

Volume

19,850

Open

$1.73

Previous Close

$1.80

Daily Range

$1.72 - $1.80

52-Week Range

$0.64 - $2.73

Dividend

$0.00

Beta (Volatility)

2.02 (High)

Price

$1.79

Volume

19,850

Open

$1.73

Previous Close

$1.80

Daily Range

$1.72 - $1.80

52-Week Range

$0.64 - $2.73

OCGN News

Why Ocugen Stock Zoomed 12% Higher Today

Eric VolkmanSep 15, 2025

Ocugen (OCGN) Q2 Revenue Jumps 20%

Motley Fool Markets TeamAug 1, 2025

1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole

Prosper Junior BakinyMay 24, 2024

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street

Sean WilliamsJan 23, 2023

Why Shares of Ocugen Jumped Thursday

James HalleyDec 29, 2022

Page 1

OCGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ocugen

Industry

Biotechnology

Sector

Health Care

Employees

116

CEO

Shankar Musunuri, PhD, MBA

Website

www.ocugen.com

Headquarters

Malvern, PA 19355, US

OCGN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-14%

Net Income Margin

-15%

Return on Equity

-777%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-12.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$609.33M

Shares Outstanding

338.52M

Volume

19.85K

Avg. Volume

7.72M

Financials (TTM)

Gross Profit

$2.02M

Operating Income

$62.92M

EBITDA

$60.53M

Operating Cash Flow

$56.96M

Capital Expenditure

$185.00K

Free Cash Flow

$57.15M

Cash & ST Invst.

$18.57M

Total Debt

$33.14M

Ocugen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$193.00K

-125.3%

Gross Profit

$193.00K

-125.3%

Gross Margin

100.00%

N/A

Market Cap

$609.33M

N/A

Market Cap/Employee

$6.41M

N/A

Employees

N/A

Net Income

$17.71M

-27.6%

EBITDA

$16.28M

-22.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$14.57M

-156.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$31.04M

+1.2%

Short Term Debt

$2.11M

+14.3%

Return on Assets

-1.53%

N/A

Return on Invested Capital

-2.96%

N/A

Free Cash Flow

$14.00M

-34.9%

Operating Cash Flow

$13.96M

-34.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.63+1.24%

ADCTADC Therapeutics S.A.

ADCTADC Therapeutics S.A.$3.83+1.32%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$2.44-1.21%

NGNENeurogene Inc.

NGNENeurogene Inc.$26.85+2.91%

FULCFulcrum Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.$7.36+3.23%

CMPXCompass Therapeutics, Inc.

CMPXCompass Therapeutics, Inc.$1.96+10.73%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.47+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

NIONio

NIONio$5.91-0.08%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$674.15+0.01%

Questions About OCGN

What is the current price of Ocugen?

Ocugen is trading at $1.80 per share.

What is the 52-week range for Ocugen?

Over the past 52 weeks, Ocugen has traded between $0.64 and $2.73.

How much debt does Ocugen have?

As of the most recent reporting period, Ocugen reported total debt of $33.14M.

How much cash does Ocugen have on hand?

Ocugen reported $18.57M in cash and cash equivalents in its most recent financial results.

What is Ocugen’s dividend yield?

Ocugen does not currently have a dividend yield.

Ocugen

Ocugen Financials at a Glance

OCGN News

Why Ocugen Stock Zoomed 12% Higher Today

Ocugen (OCGN) Q2 Revenue Jumps 20%

1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole

Can Ocugen Stock Keep Churning Higher?

Why Ocugen Stock Eked Out a Win Today

1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street

Why Shares of Ocugen Jumped Thursday

OCGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ocugen

OCGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ocugen Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OCGN

What is the current price of Ocugen?

What is the 52-week range for Ocugen?

How much debt does Ocugen have?

How much cash does Ocugen have on hand?

What is Ocugen’s dividend yield?

Premium Investing Services